FrankGOndreyMD

Otolaryngology (ENT) • Minneapolis, MN

Associate Professor, Otolaryngology, University of Minnesota Medical School

Join to view full profile

Dr. Ondrey is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ondrey's full profile

Already have an account?

Office
516 Delaware St SE
PWB Eighth floor Clinic 8a
Minneapolis, MN 55455
Phone+1 612-626-5900

Fax+1 612-676-4047

Education & Training

University of MinnesotaResidency, Otolaryngology - Head and Neck Surgery, 1991 - 1995
Hennepin HealthcareResidency, Surgery, 1989 - 1991
Rush Medical College of Rush University Medical CenterClass of 1989

Certifications & Licensure

MN State Medical License 1995 - 2024
American Board of Otolaryngology - Head and Neck Surgery Otolaryngology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Fellow (FACS) American College of Surgeons
Fellow (FAAO-HNS) American Academy of Otolaryngology - Head and Neck Surgery

Clinical Trials

Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia Start of enrollment: 2003 Jun 01
Completed
Phase 2
Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer Start of enrollment: 2006 Mar 01
Terminated
Phase 2
Pioglitazone for Oral Premalignant Lesions Start of enrollment: 2010 Feb 01
Terminated
Phase 2
The Midwest Head and Neck Cancer Consortium Multi-Institutional Parathyroid Registry Start of enrollment: 2010 Jun 09
Completed
Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion Start of enrollment: 2016 Jun 10
Active, not recruiting
Phase 2
ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Treatment Start of enrollment: 2018 May 31
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

348 citations
Phase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck Cancer
Ezra E.W. Cohen, Theodore Karrison, Masha Kocherginsky, Jeffrey Mueller, Robyn Egan
Journal of Clinical Oncology. 2014-09-01
11 citations
Irreversible ototoxicity associated with difluoromethylornithine
Christopher D. Lao, Patricia Backoff, Lawrence I. Shotland, Deborah McCarty, Tracy Eaton
Cancer Epidemiology, Biomarkers & Prevention. 2004-07-01
317 citations
Identification of a Gene Expression Signature Associated with Recurrent Disease in Squamous Cell Carcinoma of the Head and Neck
Matthew A. Ginos, Grier P. Page, Bryan S. Michalowicz, Ketan Patel, Sonja E. Volker
Cancer Research. 2004-01-01

Professional Memberships